0.135
-0.01 (-6.90%)
| Previous Close | 0.145 |
| Open | 0.140 |
| Volume | 279,400 |
| Avg. Volume (3M) | 298,735 |
| Market Cap | 41,252,160 |
| Price / Sales | 0.830 |
| Price / Book | 0.530 |
| 52 Weeks Range |
| Profit Margin | 3.77% |
| Operating Margin (TTM) | 2.69% |
| Diluted EPS (TTM) | 0.010 |
| Quarterly Revenue Growth (YOY) | 0.50% |
| Quarterly Earnings Growth (YOY) | 3.00% |
| Total Debt/Equity (MRQ) | 10.98% |
| Current Ratio (MRQ) | 3.30 |
| Operating Cash Flow (TTM) | 1.64 M |
| Levered Free Cash Flow (TTM) | -8.02 M |
| Return on Assets (TTM) | 0.46% |
| Return on Equity (TTM) | 2.29% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (MY) | Mixed | Bearish |
| Medical Instruments & Supplies (Global) | Bullish | Mixed | |
| Stock | ADVENTA | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 0.63 |
|
Adventa Bhd is engaged in investment holdings, management services, warehousing services, and the manufacturing, distribution, and supply of medical and healthcare equipment, appliances, and medical disposal products. It operates as a regional healthcare group focused on medical innovation, manufacturing excellence, and patient-centered solutions. Its segments include Investment Holdings, which involves investment in companies; Healthcare Products, which involves the manufacturing and supply of healthcare-related products and services to hospitals, healthcare centres, and pharmacies and generates maximum revenue; and Warehousing Provider, which provides storage and warehousing services. The company generates maximum revenue from Malaysia, followed by Indonesia and other countries. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 53.95% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 23 Jun 2026 | Announcement | General Meetings: Outcome of Meeting |
| 29 May 2026 | Announcement | Quarterly rpt on consolidated results for the financial period ended 31/03/2026 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 14 Jan 2020 | 30 Dec 2019 | 22 Jan 2020 | 0.07 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2020 | 0.070 | 1 | 5.34 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |